Skip to main content

Table 3 CVDs deaths attribute to hypertension in 2018 and 2002 in Tianjin, China

From: Characteristics of hypertension in the last 16 years in high prevalence region of China and the attribute ratios for cardiovascular mortality

health outcomes

Male

Female

Both sexes

Deaths No.(95%UI) Thousands

Death PAFs,%(95% UL)

Deaths No.(95%UI) Thousands

Death PAFs,%(95% UL)

Deaths No.(95%UI) Thousands

Death PAFs,%(95% UL)

2018

Ischemic heart disease

6.1(5893–6188)

61.7%(58.6–62.7)

5.7(5689–5842)

59.5%(58.3–59.9)

11.8 (11353–12205)

60.5%(59.3–63.5)

Ischemic stroke

3.9(3857–4003)

56.7%(56.5–59.6)

2.8(2793–2927)

53.5%(51.3–53.8)

6.7(6546–6701)

55.2%(54.9–56.3)

Hemorrhagic stroke

1.8(1797–1838)

66.3%(64.4–66.7)

1.2(1169–1216)

62.6%(61.5–63.2)

3.0(2991–3076)

64.43%(64.0–65.1)

other CVDs

0.1(133–139)

35.2%(34.4–35.3)

0.1(92–98)

31.4%(30.7–31.9)

0.2(229–235)

33.5%(33.4–34.0)

all CVDs

12.0(11941–12438)

60.1%(59.1–60.1)

9.8(9682–9889)

57.5%(55.9–57.7)

21.7(21201–21837)

58.8%(58.0–59.7)

2002

Ischemic heart disease

3.1(3111–3293)

61.4%(60.7–64.3)

2.6(2573–2751)

58.4%(57.6–60.1)

5.7(5696–6091)

60.2%(59.9–61.3)

Ischemic stroke

2.2(2181–2322)

58.9%(58.2–59.8)

1.6(1591–1677)

56.1%(55.3–57.3)

3.8(3808–3936)

57.6%(55.1–58.0)

Hemorrhagic stroke

2.3(2299–2382)

65.9%(65.8–68.1)

1.6(1574–1608)

63.1%(62.8–64.2)

3.9(3882–4020)

64.8%(63.9–65.3)

other CVDs

0.2(188–192)

33.4%(32.5–34.2)

0.2(199–209)

29.6%(29.2–29.9)

0.4(380–394)

31.1%(30.4–31.7)

all CVDs

7.8(7606–7913)

60.4%(60.0–61.1)

6.0(5908–6036)

57.2%(56.8–57.6)

13.8(13611–13948)

59.1%(58.9–59.4)